Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.
about
Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials.Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts SymposiumInteraction between the Kansas City Cardiomyopathy Questionnaire and the Pocock's clinical score in predicting heart failure outcomes.INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.Medication adherence: staying within the boundaries of safety.Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire.Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure.Medication management strategies used by older adults with heart failure: A systems-based analysis.A Home-Based Diaphragmatic Breathing Retraining in Rural Patients With Heart Failure.Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction.Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction: A Secondary Analysis of 2 Randomized Clinical Trials.Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.
P2860
Q34836591-7535DA28-94FA-4801-AB1E-5094494C9308Q35018046-5BD2BED2-639C-411C-B843-D9EFC7D06FFCQ35883082-DCE4D8E1-D884-4D52-959F-8EB731BBF72BQ36823724-31AE46A3-D5D2-4475-8294-46A087E0DC56Q38377133-962C31B2-FFE9-4A71-8C72-B54782B4F9AFQ38732538-78EA3DA4-6D26-46AA-A22D-744F423EE7BBQ40607480-B9AE777A-3F2B-4CFB-A5CE-3012BE332E19Q47551968-F108E1AC-6106-4885-9F31-28AC543DC091Q47680833-4EAE8CA8-8252-46D3-83BE-A2D44A098136Q48038900-9EB31869-6D9F-4AAD-BFC2-44EAEF82D783Q48513189-4E4825A9-37F2-4D77-B84D-DE98D4D1D94BQ50221183-B7DA6B77-52CD-447A-8B91-AE3992903A52Q52627988-DD738269-C5BB-4DB2-8EAB-0498C93EB9C2Q52838302-4E0C1FD6-1AF7-440A-86E2-DB66BFD3E913
P2860
Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparable performance of the ...... and reduced ejection fraction.
@ast
Comparable performance of the ...... and reduced ejection fraction.
@en
type
label
Comparable performance of the ...... and reduced ejection fraction.
@ast
Comparable performance of the ...... and reduced ejection fraction.
@en
prefLabel
Comparable performance of the ...... and reduced ejection fraction.
@ast
Comparable performance of the ...... and reduced ejection fraction.
@en
P2093
P2860
P1476
Comparable performance of the ...... and reduced ejection fraction.
@en
P2093
Anne E Platts
Eric Novak
Himad Khattak
Philip G Jones
Susan M Joseph
Suzanne V Arnold
Victor G Dávila-Román
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.113.000359
P577
2013-10-15T00:00:00Z